NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 96 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $324,736 | -64.0% | 303,492 | -12.9% | 0.02% | -66.7% |
Q2 2023 | $901,968 | -36.5% | 348,250 | 0.0% | 0.04% | -33.8% |
Q1 2023 | $1,420,860 | -18.7% | 348,250 | 0.0% | 0.07% | -34.6% |
Q4 2022 | $1,748,215 | -58.1% | 348,250 | +9.3% | 0.10% | -62.7% |
Q3 2022 | $4,169,000 | +2.0% | 318,750 | 0.0% | 0.28% | +13.0% |
Q2 2022 | $4,086,000 | -13.9% | 318,750 | +2.4% | 0.25% | +5.6% |
Q1 2022 | $4,747,000 | -13.6% | 311,250 | +0.3% | 0.23% | +13.6% |
Q4 2021 | $5,495,000 | -15.7% | 310,250 | 0.0% | 0.21% | -29.2% |
Q3 2021 | $6,521,000 | +6.6% | 310,250 | 0.0% | 0.29% | -4.6% |
Q2 2021 | $6,118,000 | -31.8% | 310,250 | +0.5% | 0.30% | -26.2% |
Q1 2021 | $8,975,000 | -4.1% | 308,750 | 0.0% | 0.41% | -0.2% |
Q4 2020 | $9,354,000 | +90.4% | 308,750 | 0.0% | 0.41% | +46.3% |
Q3 2020 | $4,912,000 | -19.4% | 308,750 | 0.0% | 0.28% | -32.9% |
Q2 2020 | $6,095,000 | +60.1% | 308,750 | 0.0% | 0.42% | +39.7% |
Q1 2020 | $3,807,000 | -32.9% | 308,750 | +0.6% | 0.30% | -19.0% |
Q4 2019 | $5,676,000 | +17.1% | 307,000 | -12.3% | 0.37% | +46.3% |
Q3 2019 | $4,848,000 | -5.1% | 350,000 | +0.3% | 0.26% | +22.6% |
Q2 2019 | $5,109,000 | – | 349,000 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 3,766,666 | $79,175,000 | 44.14% |
Ponoi II Management, LLC | 1,298,908 | $27,303,000 | 40.46% |
Column Group LLC | 15,396,116 | $323,626,000 | 36.81% |
Ponoi Management, LLC | 1,298,908 | $27,303,000 | 24.24% |
Euclidean Capital LLC | 832,274 | $17,494,000 | 8.50% |
StepStone Group LP | 1,573,357 | $33,072,000 | 2.14% |
Octagon Capital Advisors LP | 200,000 | $4,204,000 | 1.04% |
Redmile Group, LLC | 2,505,118 | $52,658,000 | 0.92% |
BVF INC/IL | 955,000 | $20,074,000 | 0.78% |
Boxer Capital, LLC | 500,000 | $10,510,000 | 0.37% |